{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:33:23Z","timestamp":1792359203133,"version":"4.4.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Cognitive impairment, and dementia, are major contributors to global burden of death and disability, with projected increases in prevalence in all regions of the world, but most marked increases in low and middle-income countries. Hypertension is a risk factor for both Vascular Cognitive Impairment and Alzheimer's disease, the two most common causes of dementia, collectively accounting for 85% of cases. Key end-organ pathological mechanisms, for which hypertension is proposed to be causative, include acute and covert cerebral ischemia and hemorrhage, accelerated brain atrophy, cerebral microvascular rarefaction and endothelial dysfunction, disruption of blood-brain barrier and neuroinflammation that affects amyloid pathologies. In addition to the direct-effect of hypertension on brain structure and microvasculature, hypertension is a risk factor for other diseases associated with an increased risk of dementia, most notably chronic kidney disease and heart failure. Population-level targets to reduce the incidence of dementia are a public health priority. Meta-analyses of blood pressure lowering trials report a significant reduction in the risk of dementia, but the relative (7\u201311%) and absolute risk reductions (0.4% over 4 years) are modest. However, given the high lifetime prevalence of both conditions, such relative risk reduction would translate into important population-level reductions in dementia globally with effective screening and control of hypertension. Optimal blood pressure target, especially in older adults with orthostatic hypotension, and antihypertensive agent(s) are uncertain. In this review article, we will detail the observational and interventional evidence linking hypertension with cognitive impairment, summarizing the mechanisms through which hypertension causes cognitive decline.<\/jats:p>","DOI":"10.3389\/fneur.2022.821135","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T08:09:27Z","timestamp":1643962167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":161,"title":["Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts"],"prefix":"10.3389","volume":"13","author":[{"given":"Michelle","family":"Canavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA."},{"key":"B3","unstructured":"KumarA\n            SidhuJ\n            GoyalA\n            TsaoJW\n          Treasure Island, FLStatPearls PublishingAlzheimer Disease StatPearls2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: A systematic analysis for the global burden of disease study 2016","volume":"18","author":"GBD","year":"2019","journal-title":"Lancet Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/eurheartj\/ehy288","article-title":"Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension","volume":"39","author":"Abell","year":"2018","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S330","DOI":"10.1016\/j.jalz.2013.05.1777","article-title":"Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study","volume":"10","author":"Alp\u00e9rovitch","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","article-title":"Blood pressure from mid- to late life and risk of incident dementia","volume":"89","author":"McGrath","year":"2017","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"Cd004034","DOI":"10.1002\/14651858.CD004034.pub4","article-title":"Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia","volume":"5","author":"Cunningham","year":"2021","journal-title":"Cochr Database Syst Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1016\/S2214-109X(19)30074-9","article-title":"Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data","volume":"7","author":"Mukadam","year":"2019","journal-title":"Lancet Glob Health."},{"key":"B15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet Lond Engl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S1474-4422(16)30073-4","article-title":"Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"15","author":"Feigin","year":"2016","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet Lond Engl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","article-title":"Hypertension-induced cognitive impairment: from pathophysiology to public health","volume":"17","author":"Ungvari","year":"2021","journal-title":"Nat Rev Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"105460","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105460","article-title":"Association between small vessel disease markers, medial temporal lobe atrophy and cognitive impairment after stroke: a systematic review and meta-analysis","volume":"30","author":"Wang","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1212\/WNL.0000000000007142","article-title":"WMH and long-term outcomes in ischemic stroke: a systematic review and meta-analysis","volume":"92","author":"Georgakis","year":"2019","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.trci.2019.02.001","article-title":"White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities","volume":"5","author":"Alber","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/STROKEAHA.119.026170","article-title":"Global burden of small vessel disease-related brain changes on MRI predicts cognitive and functional decline","volume":"51","author":"Jokinen","year":"2020","journal-title":"Stroke."},{"key":"B24","doi-asserted-by":"publisher","first-page":"716632","DOI":"10.3389\/fneur.2021.716632","article-title":"Cognitive impairment after intracerebral hemorrhage: a systematic review of current evidence and knowledge gaps","volume":"12","author":"Potter","year":"2021","journal-title":"Front Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"H1128","DOI":"10.1152\/ajpheart.00780.2016","article-title":"Cerebral microhemorrhages: mechanisms, consequences, and prevention","volume":"312","author":"Ungvari","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","article-title":"Midlife blood pressure, plasma \u03b2-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study","volume":"59","author":"Shah","year":"2012","journal-title":"Hypertens Dallas Tex 1979."},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0197-4580(00)00106-8","article-title":"Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study","volume":"21","author":"Petrovitch","year":"2000","journal-title":"Neurobiol Aging."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/jcbfm.2013.143","article-title":"Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension","volume":"33","author":"Toth","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","article-title":"Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults","volume":"14","author":"Bowman","year":"2018","journal-title":"Alzheimers Dement J Alzheimers Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for \u03b2-amyloid deposition in healthy aging: vascular and genetic effects","volume":"70","author":"Rodrigue","year":"2013","journal-title":"JAMA Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1212\/WNL.0b013e31827f0f7f","article-title":"Frequency of and risk factors for poor cognitive performance in hemodialysis patients","volume":"80","author":"Sarnak","year":"2013","journal-title":"Neurology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1532-5415.2009.02670.x","article-title":"Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study","volume":"58","author":"Yaffe","year":"2010","journal-title":"J Am Geriatr Soc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1212\/01.wnl.0000225182.15532.40","article-title":"Cognitive impairment in hemodialysis patients is common","volume":"67","author":"Murray","year":"2006","journal-title":"Neurology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/j.ajkd.2008.05.004","article-title":"Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) study","volume":"52","author":"Kurella Tamura","year":"2008","journal-title":"Am J Kidney Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/toxins10070303","article-title":"The impact of uremic toxins on cerebrovascular and cognitive disorders","volume":"10","author":"Assem","year":"2018","journal-title":"Toxins."},{"key":"B36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1681\/ASN.2018050462","article-title":"Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients","volume":"30","author":"Findlay","year":"2019","journal-title":"J Am Soc Nephrol JASN."},{"key":"B37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/jnnp-2019-320526","article-title":"Disentangling the multiple links between renal dysfunction and cerebrovascular disease","volume":"91","author":"Kelly","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","article-title":"Cognitive impairment in CKD: pathophysiology, management, and prevention","volume":"74","author":"Drew","year":"2019","journal-title":"Am J Kidney Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/archinternmed.2010.502","article-title":"Albuminuria and decline in cognitive function: The ONTARGET\/TRANSCEND studies","volume":"171","author":"Barzilay","year":"2011","journal-title":"Arch Intern Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.HYP.0000168052.00426.65","article-title":"Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy","volume":"46","author":"O'Rourke","year":"2005","journal-title":"Hypertension."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e2956","DOI":"10.1212\/WNL.0000000000012113","article-title":"Kidney function, kidney function decline, and the risk of dementia in older adults: a registry-based study","volume":"96","author":"Xu","year":"2021","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jalz.2014.05.1758","article-title":"Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline","volume":"11","author":"Bos","year":"2015","journal-title":"Alzheimers Dement J Alzheimers Assoc."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1161\/STROKEAHA.112.655837","article-title":"Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility","volume":"43","author":"Webb","year":"2012","journal-title":"Stroke."},{"key":"B47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1007\/s11606-021-06954-8","article-title":"Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer's disease: a systematic review and meta-analysis","volume":"36","author":"Papanastasiou","year":"2021","journal-title":"J Gen Intern Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the American Heart Association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertens Dallas Tex 1979."},{"key":"B50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(03)00305-3","article-title":"Vascular cognitive impairment","volume":"2","author":"O'Brien","year":"2003","journal-title":"Lancet Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1212\/WNL.0000000000007543","article-title":"Blood pressure and dementia: what the SPRINT-MIND trial adds and what we still need to know","volume":"92","author":"Peters","year":"2019","journal-title":"Neurology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e038971","DOI":"10.1136\/bmjopen-2020-038971","article-title":"Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2020","journal-title":"BMJ Open."},{"key":"B53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet Lond Engl."},{"key":"B55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet Lond Engl."},{"key":"B57","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/awf077","article-title":"Hypertension and cerebral white matter lesions in a prospective cohort study","volume":"125","author":"de Leeuw","year":"2002","journal-title":"Brain J Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.119.041603","article-title":"Effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older people (INFINITY)","volume":"140","author":"White","year":"2019","journal-title":"Circulation."},{"key":"B59","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaneurol.2021.0178","article-title":"Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer Disease: secondary analysis of the SPRINT MIND randomized trial","volume":"78","author":"Nasrallah","year":"2021","journal-title":"JAMA Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jama.2019.10551","article-title":"Association of intensive vs standard blood pressure control with cerebral white matter lesions","volume":"322","author":"Nasrallah","year":"2019","journal-title":"JAMA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1161\/01.STR.0000091397.81767.40","article-title":"Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial","volume":"34","author":"Fransen","year":"2003","journal-title":"Stroke."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol Aging."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: New evidence from the systolic hypertension in europe (syst-eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08037050600771583","article-title":"Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review","volume":"15","author":"Zanchetti","year":"2006","journal-title":"Blood Pressure."},{"key":"B65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.14336\/AD.2020.1111","article-title":"Effects of antihypertensive drugs on cognitive function in elderly patients with hypertension: a review","volume":"12","author":"Yang","year":"2021","journal-title":"Aging Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e2012252","DOI":"10.1001\/jamanetworkopen.2020.12252","article-title":"Effects of candesartan vs lisinopril on neurocognitive function in older adults with executive mild cognitive impairment: a randomized clinical trial","volume":"3","author":"Hajjar","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2019.10575","article-title":"Association of midlife to late-life blood pressure patterns with incident dementia","volume":"322","author":"Walker","year":"2019","journal-title":"JAMA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.arr.2008.11.001","article-title":"Blood pressure and the risk for dementia: a double edged sword","volume":"8","author":"Kennelly","year":"2009","journal-title":"Ageing Res Rev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/jamainternmed.2014.8164","article-title":"Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs","volume":"175","author":"Mossello","year":"2015","journal-title":"JAMA Intern Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12877-021-02479-1","article-title":"Associations of changes in late-life blood pressure with cognitive impairment among older population in China","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Geriatr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.exger.2019.02.017","article-title":"Orthostatic hypotension and cognition in older adults: a systematic review and meta-analysis","volume":"120","author":"Iseli","year":"2019","journal-title":"Exp Gerontol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.26355\/eurrev_201712_13934","article-title":"Relationship between blood pressure variability and target organ damage in elderly patients","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/HYPERTENSIONAHA.114.04568","article-title":"Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk","volume":"65","author":"B\u00f6hm","year":"2015","journal-title":"Hypertension."},{"key":"B75","doi-asserted-by":"publisher","first-page":"f4600","DOI":"10.1136\/bmj.f4600","article-title":"Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study","volume":"347","author":"Sabayan","year":"2013","journal-title":"Bmj."},{"key":"B76","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.116.025667","article-title":"Day-to-day blood pressure variability and risk of dementia in a general Japanese elderly population: The Hisayama Study","volume":"136","author":"Oishi","year":"2017","journal-title":"Circulation."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e1002933","DOI":"10.1371\/journal.pmed.1002933","article-title":"Variation in blood pressure and long-term risk of dementia: a population-based cohort study","volume":"16","author":"Ma","year":"2019","journal-title":"PLoS Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/ajh\/hpaa119","article-title":"Blood pressure variability and dementia: a state-of-the-art review","volume":"33","author":"Ma","year":"2020","journal-title":"Am J Hypertens."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","article-title":"Hypertension management in older and frail older patients","volume":"124","author":"Benetos","year":"2019","journal-title":"Circ Res."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.821135\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T08:09:31Z","timestamp":1643962171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.821135\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":79,"alternative-id":["10.3389\/fneur.2022.821135"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.821135","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"article-number":"821135"}}